跳至主要内容
临床试验/NCT04392609
NCT04392609Unknown不适用

Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI, and Comparison of MR Imaging Evaluation Between NCT and NCRT

Ziqiang Wang,MD1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2020年1月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
180
试验地点
1
主要终点
pTRG

研究概览

简要总结

This trial was designed to to study whether there is a difference in MRI image evaluation between NCRT and NCT, and try to build a model to predict the efficacy of neoadjuvant therapy by combining multiple imaging indexes.

详细描述

This study was designed as a retrospective case-control study. All 116 patients with locally advanced rectal cancer who started neoadjuvant chemoradiotherapy and underwent radical surgery in West of China Hospital and completed the required MR examination before and after neoadjuvant treatment were included from March 2016 to December 2019. MRI imaging indicators of patients before and after neoadjuvant therapy, including tumor location, longitudinal diameter, circumferential Angle, DWI signal, mrTRG and texture feature data, were retrospectively collected to analyze the changes before and after treatment, and compared with patients receiving NCT in PART1. At the same time, indicators with statistical differences will be included in the construction of models predicting different pathological outcomes after NCT and NCRT, and the efficacy of the models was evaluated through c-index values and ROC analysis of bootstrap resampling 500 times.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • pathological diagnosis of rectal cancer;
  • received neoadjuvant chemoradiotherapy before surgery;
  • before neoadjuvant therapy and before surgery, the patients received thin and high resolution MRI examination of the rectum.
  • before neoadjuvant therapy, colonoscopy, rectal contrast-enhanced ultrasound or MRI showed that the lower margin of the tumor was within 12cm from the anal margin;
  • pre-neoadjuvant clinical stage II/III (AJCC 7th edition);

排除标准

  • simultaneous distant metastatic tumor should be considered at the first diagnosis;
  • patients with distant metastasis were not considered at the initial diagnosis;
  • with other malignant tumors;
  • before neoadjuvant therapy, patients had received other relevant treatments;
  • to undergo palliative surgery or emergency surgery in the course of neoadjuvant therapy;

结局指标

主要结局

pTRG

时间窗: within 2 week after surgery

pathological tumour regression grading

次要结局

未报告次要终点

研究者

发起方
Ziqiang Wang,MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ziqiang Wang,MD

physician

West China Hospital

研究点 (1)

Loading locations...

相似试验